Connealy Pamela Ann

CFO & COOPyxis Oncology, Inc. (PYXS) · full profile →Form 4 · filed Nov 27, 2024
Net Buying
Open-Market Buys
$174K
Open-Market Sells
$0
Net Open-Market Flow
$174K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2024Buy(P)5K$2.00$11K1.1M
Nov 26, 2024Buy(P)83K$1.96$163K1.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-131606) within minutes of acceptance. Every field above traces to the original document. Verify it directly: